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Medullary Thyroid Carcinoma: Australian Experience with
Genetic Testing
Janet L. Ward,* Valentine J. Hyland,* David S. Andrew,* Debbie J. Marsh,'
and Bruce G. Robinson*
Linkage analysis has been performed in four pedigrees with multiple endocrine neoplasia type 2A
(MEN 2A) or familial medullary thyroid carcinoma (MTC) using pericentromeric chromosome 10
probes. Important information regarding carrier status has been provided in 10 individuals, many of
whom would not have heen identified by pentagastrin stimulation testing. We have also used pulsed
field gel electrophoresis (PFGE) to link the probes H4JRBP and pMCK2 to a 150 kb fragment. Using
PFGE, no evidence was found in DNA from lymphocytes of a major DNA rearrangement in two
individuals affected with MEN 2A and an individual with MEN2B compared with normals. Metastatic
MTC from one patient has been used to generate a cDNA library which will be used to screen for
candidate MEN 2A and MEN 2B gene(s). (Henry Ford Hosp MedJ 1992;40:220-3)

he identification of carriers of the gene(s) responsible for
the development of the multiple endocrine neoplasia type
2A (MEN 2A) syndrome has traditionally relied on provocative
pentagastrin-stimulated calcitonin testing. Difficulties are frequendy encountered in the interpretation of this test. These include dependence upon age at time of test performance and nonparallelism of diluted samples to the assay standard curve. In "at
risk" individuals the test should ideally be repeated annually in
an attempt to identify the prematignant stage of C-cell hyperplasia.
The availability of closely hnked fianking markers for the
MEN 2A (1,2) locus has made it possible to accurately predict
gene carrier status on a single blood sample when linkage has
been established in the family.
We have performed linkage analysis in four of six Australian
families with either MEN 2A or familial medullary thyroid carcinoma (MTC) and have been able to provide important carrier
status information to 10 individuals.
In addition, we have performed pulsed field gel electrophoresis (PFGE) to improve the genetic map in the lOql 1.2 region and have generated a cDNA library from MTC which will
be helpful in the isolation of candidate MEN 2A gene(s).

T

Materials and Methods
Linkage analysis
Genomic DNA used for linkage analysis was extracted from
peripheral blood leukocytes by a method described previously
(3). Restriction enzyme digested DNA was electrophoresed in
0.8% agarose gels and transferred to nylon filters (Genescreen
Plus) by Southem blotting (4).
Probes
Eight probes (H4.IRBP [RBP3], pMCK2 [D10S15], TB10.163
[D10S22J, and pGEM-32 [FNRB]) were used to study linkage
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relationships in four fainilies. Gel isolated fragrnents of the cosmid probes MEN203 and cIRBP.9 (RBP3) were also used in
linkage analysis. A 9 kb DNA fragment isolated by a Noti,
Bglll double digestion of the cosmid MEN203 detected the
Bglll polymorphism but stdl contained some repetitive sequences. A subsequent Mspl digestion of the above fragment
isolated a unique 2.2 kb subfragment which also detected the
Bglll polymorphism. A unique 3 kb fragment isolated by a
Noti, TaqI double digestion of the cosmid probe cIRBP.9 detected the TaqI polymorphism. The probes H4.IRBP and
pMCK2 were also used in pulsed field gel analysis.
Insert DNA was isolated from the probes and labeled with
random primers to a specific activity of 1 x 10^ cpm/|ag. Filters
were hybridized ovemight. Final washes were in 2 x SSC, 1%
SDS at 42 °C, or 0.1 x SSPE, 0.1% SDS at 65 °C. Filters were
stripped in 0.2N NaOH and checked for removal of probe prior
to reuse.
Pulse field gel electrophoresis
PFGE was perfoimed on DNA from our control individuals.
In two controls, DNA was obtained from independent lymphoblastoid cell lines and in the other two controls DNA was obtained from lymphocytes isolated from fresh blood. The DNA
from two independent MEN 2A individuals and the MEN 2B individual was isolated from lymphocytes of fresh blood. DNA
was isolated from the lymphoblastoid cell line CY6. This cell
line contains a single 10:16 translocation in a mouse, A9 background. The chromosome 10 content was 10pter-10q26 (this
cell line was provided by D. F. Callen).
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Fig I—DNA typing of family I with closely linked markers.
Solid circlelsolid square = individuals with proven MEN 2A.
Numbers in symbols indicate age in years at last pentagastrin
stimulation test. -¥ or - = positive or negative test result.

Fig 2—DNA typing of family 3 with closely linked markers.
Solid circlelsolid square = individuals with proven MEN 2A.
Half-filled circles/half-filled squares = individuals with familial MTC. Half-shaded circles/half-shaded .squares = individuals with Hirchsprung's disease. Numbers in symbols indicate
age in years at last pentagastrin stimulation test, -t- or - = positive or negative test result.

Several ob.servations can be rnade from our famities. Individual III-2 in pedigree 1 (Fig 1) has a high probability of being a
gene carrier. In pedigree 2 a recombination event has been idenA Pharmacia PFGE apparatus with a hexagonal electrode was
tified in one individual between the RBP3 and D10S22
used. The buffer was 0.5 x TBE and the gel was 1 % agarose (Be- (TBI0.163) loci. In pedigree 3 (Fig 2) the index case II-3 has
thesda Research Laboratories). DNA in 0.7% low melting point
both Hirschprung's disease and MTC. Several of this individagarose (Pharmacia) was digested with restriction endonuual's siblings died in infancy or childhood with complications
cleases Not 1, Nru 1, and Mlu 1 (New England Biolabs). Samples of Hirschpmng's disease. Hirschprung's disease and MTC do
were electrophoresed at 150 mA constant current, 5 °C, with a
not appear to be linked in this family as individual III-2 has
switching of 70s for 30 hours. To resolve the 1,600 kb Mlul
MTC but normal bowel function. Southern analysis of DNA exfragment, the buffer was reduced to 0.25 x TBE and the samples
tracted from stored paraffin blocks of tissue from individual II-1
electrophoresed at 80 mA constant current, 5 °C, with a switchin pedigree 3 was not possible as the DNA was degraded. Linking of 1,200s for five days, and then with a switching of 70s for
age analysis has been particularly helpful in individual III-l in
20 hours.
this pedigree as the result of an initial pentagastrin stimulation
test revealed nonparallelism of diluted samples to the assay
standard curve. Pedigree 4 has been uninformative when anacDNA library
lyzed with six different linked probes. Blood samples are curTotal RNA was prepared from metastatic MTC in a cervical
rently
being collected from individuals in pedigree 5, which is
lymph node by standard GTC/CsCl procedures (5). From 70 [ig
also
of
interest in that two individuals have recently developed
total RNA, 5.92 ng poly A+ RNA was collected by column chropositive
pentagastrin stimulation tests. DNA samples from pedmatography using oligo dT cellulose columns (Pharmacia).
igree
6
are
being obtained.
The cDNA library was constructed using the lambda ZAPLinkage analysis in our families has been particularly helpful
cDNA synthesis kit (Stratagene).
in establishing that one individual, aged 8 years, is a gene carrier
and that nine individuals between the ages of 8 and 35 years
Results
have been reasonably excluded as gene carriers. Flanking markLinkage analysis
ers have been informative only in pedigree 3.
We have collected data on six families with either MEN 2A or
familial MTC and have performed linkage analysis in four of
Pulsedfieldgel mapping
these families. The results of linkage analysis are shown in Figs
Results are shown in Tables 1 and 2 and Fig 3 (A and B).
1 and 2.
H4.1RBP and pMCK2 hybridize to Noti restriction fragments
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Table 2
Hybridization with pMCK2

Table 1
Hybridization with H.4IRBP
Restriction Endonuclease
Nrul
Mlul

Cell
Line

Noti

Controls 1 and 2

100 kb

800 kb

Controls 3 and 4*

100 kb

CY6
MEN2A 1 and 2/
MEN2B1

ND
Nl)

800,
900 kb
800 kb
800 kb

150, 250, 600, 750,
and 1,600 kb
150,250,600,750,
and 1,600 kb
250 and 1,600 kb
150, 250, 600,
750, and 1,600 kb

Restriction Endonuclease
Nrul
Mlul

Cell
Line

Noti

Controls 1 and 2

400 kb

800 kb

Controls 3 and 4*

400 kb

CY6
MEN2A I and 2/
MEN2B1

ND
ND

800,
900 kb
800 kb
800 kb

150, 2.50, 600, 750,
and 1,600 kb
150,250,600,750,
and 1,600 kb
250 kb
1.50, 2.50, 600,
750, and 1,600 kb

*No Mlul hybridization fragments were detected.
ND = not determined.

*No Mlul hybridization fragments were detected.
ND - not determined.

of 100 kb and 400 kb, respectively. Both probes hybridized to an
800 kb Nrul restriction fragment for controls 1 and 2, and to 800
and 900 kb Nml restriction fragments for controls 3 and 4. In
addition, both probes hybridized to Mlu 1 restriction fragments
of 150,250,600,750, and 1,600 kb for three of the four controls.
DNA from control 4 that hybridized to the two probes was unresolved on the gels. The pattem of hybridization to the Mlul restriction fragments indicates partial restriction of DNA at the
Mlul restriction sites adjacent to or in the RBP3 and DIGS 15
loci. For CY6, H4.IRBP hybridized to Mlul fragments of 250
and 1,600 kb and pMCK2 hybridized to only a 250 kb Mlu 1 restriction fragment. This indicates that the genomic sequence for

1 2 3 4 5 6 7 8 9 1 0 11 1?
C
IIA IIA i l B C r H

RBP3, on the 10:16 translocation, contains an Mlul restriction
site and the 250 and 1,600 kb restriction fragments are adjacent
on the chromosome.
No change in the pattem of hybridization was observed for
the two MEN 2A or MEN 2B individuals. No detectable rearrangement of the RBP3 or DlOSl5 loci was observed in these
individuals in DNA from lymphocytes.
cDNA Library
The cDNA library which was generated from metastatic
MTC is currently being screened for candidate genes. 10^ clones
are being screened initially using afiow-sortedhuman chromo-

1

c

3 4 5 6 7 8 9 10 1112
H
IIA IIA IIB C

/

i

H.4IRB

pMCK2

Fig 3—A) autoradio graph (left) offilter hybridized with H4.IRBP, and B) autoradiograph (right) ofthe same filter hybridized with
pMCK2. Lane 1, control I MM; lane 2, control I Nrul; lane 3, MEN2A-1 Mlul; lane 4, MEN2A-1 Nrul; lane 5, MEN2A-2 Mlul; lane
6, MEN2A-2 Nrul; lane 7, MEN2B-1 Mlul; lane 8, MEN2B-2 Nrul; lane 9. control 3 Mlul; lane 10, control 3 Nrul; lane 11, CY6
Mlul; lane 12. CY6 Nrul. DNA standards are shown to the left of lane I in photograph B; the L DNA standards are concatamers of
Lambda cI857 (New England Biolabs); and the Y DNA standards are yeast chromosome markers of Saccharomyces cerevisae strain
YPH80 (New England Biolabs). Faint signals are highlighted with a solid square.
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some 10 library (ATCC 57736). The insert sizes of six random
recombinant clones ranged from 0.5 to 2 kb.
A panel of hybrid cell lines will then be used to identify those
clones which localize to the centromeric region of chromosome
10.

Discussion
Accurate identification of MEN 2A gene carriers is now possible using probes closely linked to the gene for MEN 2A
(MEN2A). This enables intensive follow-up of identified carriers with annual pentagastrin stimulation testing and enables
early identification of premalignant C-cell hyperplasia. Thyroidectomy in patients with only C-cell hyperplasia has been
shown (6) to significantly reduce morbidity and mortality due to
MTC. In contrast, tho.se individuals in whom the gene(s) is not
present do not require regular pentagastrin testing. It is unlikely
that the gene carrier we have identified would have been identified by pentagastrin testing because of the low sensitivity of this
test at ages less than 12 years (7).
MEN2A has been linked to the lOql 1.2 region (8), and since
recombination fractions in the pericentromeric regions of chromosomes may underestimate the physical distance between the
locus and linked markers, we have begun constructing a physical map ofthe lOql 1.2 region. Our data show that two markers,
pMCK2 and H4.IRBP, are linked by a 150 kb Mlul fragment.
Orientation ofother markers and the use of hybrid cell lines in
PFGE wdl enable further expansion of this map.
Since our PFGE data do not indicate major DNA rearrangement in DNA of lymphocytes from patients with MEN 2A, we
have commenced screening of an MTC cDNA library based on
the hypothesis that pathogenic mRNA molecules should be ex-
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pressed in MTC. Those cDNAs which are mapped to lOql 1.2
will be examined closely as potential MEN2A candidate genes.
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